The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
MxT Biotech
Seoul, South Korea
A
1-10 Employees
2021
Key takeaway
MxT Biotech is advancing nanomedicine through its Hydroporator® platform, which enables highly effective delivery of various therapeutic cargos, including plasmid DNA, mRNA, and nanoparticles, into primary cells.
Reference
Product
Microfluidic and nanofluidic intracellulardelivery - MxT Biotech :: Microfluidics x Therapy
Advanced Science (IF=16.806)
Femtobiomed
Seongnam-si, South Korea
A
11-50 Employees
2011
Key takeaway
FEMTOBIOMED.inc focuses on advancing targeted gene delivery through multiplexed cell therapeutics, highlighting their innovative approach in the field of nanomedicine.
Reference
Core business
FEMTOBIOMED
Spidercore Inc.
Daejeon, South Korea
A
1-10 Employees
2020
Key takeaway
Spidercore is focused on enhancing gene therapy through its AI engine, which analyzes nucleotide properties to discover reliable gene therapies. This approach aligns with the emerging field of nanomedicine by utilizing modern genetics to develop innovative treatments and improve patient outcomes.
Reference
Core business
Spidercore Inc.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Promedius Inc.
Seoul, South Korea
A
11-50 Employees
2019
Key takeaway
Promedius Inc. focuses on advancing medical technology through AI, which could play a significant role in enhancing nanomedicine applications. Their innovative approach, particularly in areas like osteoporosis detection, highlights the potential for AI to transform medical diagnostics and treatment.
Reference
Core business
Promedius Inc. | The Next Generation of Medical AI
The Next Generation of Medical AI
Genuv
Seoul, South Korea
A
11-50 Employees
2016
Key takeaway
Genuv is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases by stimulating neural stem cells and restoring central nervous system (CNS) function. Their innovative approach goes beyond conventional methods, targeting immune cells and promoting neuroprotection and neurogenesis, making significant strides in drug discovery for CNS diseases.
Reference
Core business
Genuv
Biopharmaceutical company. 신약발굴 플랫폼 기술을 바탕으로 퇴행성 뇌질환, 면역질환, 암질환 등, 난치성 질환분야에서 치료제를 개발하는 연구 중심 신약 개발 기업.
BIORCHESTRA
Chungju-si, South Korea
A
1-10 Employees
2016
Key takeaway
At BIORCHESTRA, the focus is on developing innovative RNA medicines and delivery systems that address unmet medical needs, particularly in neurodegenerative and rare diseases of the Central Nervous System. Their advanced technology enables efficient encapsulation and targeted delivery of RNA therapeutics, which is crucial for enhancing patient outcomes.
Reference
Core business
BIORCHESTRA – Innovative RNA Therapeutics
Celltrion
Incheon, South Korea
A
501-1000 Employees
2002
Key takeaway
Celltrion is a global biopharmaceutical company that emphasizes its strong R&D capabilities and commitment to delivering innovative biologics, which could be relevant in the context of advancements in nanomedicine. With a focus on improving patient care and a robust infrastructure for biopharmaceutical development, Celltrion is well-positioned to contribute to the evolving landscape of medical technologies.
Reference
Product
Technology
AIRS Medical
Seoul, South Korea
A
11-50 Employees
2018
Key takeaway
AIRS Medical Inc. is revolutionizing healthcare through innovative automated solutions, such as their venipuncture system and MRI enhancement technology. Their focus on digital transformation and data-driven healthcare aims to improve efficiency and patient outcomes in the medical industry.
Reference
Core business
AIRS Medical Inc. – Official website of AIRS Medical Inc., Healthcare AI-Solution provider offering MRI Enhancement solution, Blood collection aid robits.
MediHeroes
Seoul, South Korea
A
1-10 Employees
2020
Key takeaway
MediHeroes is an international B2B medical marketplace that connects quality medical supplies and service sellers with buyers across countries, addressing concerns about product verification and seller trustworthiness. Their platform includes innovative technologies and a dedicated training program for startups aiming to expand globally.
Reference
Core business
B2B Medical Platform | MediHeroes | MedicalDevice
COVID-19 test kits | MediHeroes is an international B2B medical marketplace for quality MedicalDevices.
JNPMEDI Inc.
Seoul, South Korea
A
11-50 Employees
2020
Key takeaway
JNPMEDI is focused on enhancing clinical trial solutions through advanced digital technologies like blockchain and cloud, aiming to improve data integrity and operational efficiency. Their commitment to integrating these technologies into clinical research could be relevant for advancements in nanomedicine.
Reference
Core business
About Us | JNPMEDI
A group of problem-solvers in the IT and pharma industry gathered for the sole purpose of becoming a market disruptor in the market to offer the highest level of data integrity and operational efficiency.
Technologies which have been searched by others and may be interesting for you:
The Nanomedicine industry in South Korea presents significant opportunities and challenges for potential stakeholders. A strong regulatory framework governs the sector, with the Ministry of Food and Drug Safety overseeing the approval processes for nanomedicine products. It is crucial to understand these regulations, as compliance can impact market entry and product development timelines. The industry benefits from South Korea's advanced research facilities and a robust pharmaceutical sector, fostering innovation and collaboration between academia and industry. However, challenges exist, including high competition among local and international players, which can affect market share and pricing strategies. Environmental concerns related to nanomaterials are also gaining attention, requiring companies to adopt sustainable practices and address safety issues. On the global stage, South Korea's nanomedicine market is increasingly relevant, aided by government initiatives supporting research and development. This international focus opens avenues for partnerships and exports, enhancing growth potential. Understanding these key factors will be essential for anyone looking to navigate the Nanomedicine landscape in South Korea effectively.
Some interesting numbers and facts about your company results for Nanomedicine
Country with most fitting companies | South Korea |
Amount of fitting manufacturers | 25 |
Amount of suitable service providers | 9 |
Average amount of employees | 11-50 |
Oldest suiting company | 2002 |
Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for Nanomedicine
What are related technologies to Nanomedicine?
Based on our calculations related technologies to Nanomedicine are Glass, Superconductors, High-Performance Materials, Raw Materials, Phase Change Materials
Who are Start-Ups in the field of Nanomedicine?
Start-Ups who are working in Nanomedicine are MxT Biotech
Which industries are mostly working on Nanomedicine?
The most represented industries which are working in Nanomedicine are Medical, Biotechnology, Other, IT, Software and Services, Pharmaceuticals
How does ensun find these Nanomedicine Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.